These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24124363)

  • 1. Preparation and characterization of gadolinium-loaded PLGA particles surface modified with RGDS for the detection of thrombus.
    Zhang Y; Zhou J; Guo D; Ao M; Zheng Y; Wang Z
    Int J Nanomedicine; 2013; 8():3745-56. PubMed ID: 24124363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and evaluation of Fe₃O₄-based PLGA nanoparticles carrying rtPA used in the detection of thrombosis and in targeted thrombolysis.
    Zhou J; Guo D; Zhang Y; Wu W; Ran H; Wang Z
    ACS Appl Mater Interfaces; 2014 Apr; 6(8):5566-76. PubMed ID: 24693875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and initial characterization of biodegradable particles containing gadolinium-DTPA contrast agent for enhanced MRI.
    Doiron AL; Chu K; Ali A; Brannon-Peppas L
    Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17232-7. PubMed ID: 18796605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nile Red Loaded PLGA Nanoparticles Surface Modified with Gd-DTPA for Potential Dual-Modal Imaging.
    Li Q; Li C; Tong W
    J Nanosci Nanotechnol; 2016 Jun; 16(6):5569-76. PubMed ID: 27427598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
    Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
    Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
    Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
    Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.
    Wang M; Zhang Y; Feng J; Gu T; Dong Q; Yang X; Sun Y; Wu Y; Chen Y; Kong W
    Int J Nanomedicine; 2013; 8():1141-54. PubMed ID: 23658482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RGD modified PLGA/gelatin microspheres as microcarriers for chondrocyte delivery.
    Tan H; Huang D; Lao L; Gao C
    J Biomed Mater Res B Appl Biomater; 2009 Oct; 91(1):228-38. PubMed ID: 19388090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects.
    Tahara K; Yamamoto H; Hirashima N; Kawashima Y
    Eur J Pharm Biopharm; 2010 Mar; 74(3):421-6. PubMed ID: 20034563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levofloxacin loaded chitosan and poly-lactic-co-glycolic acid nano-particles against resistant bacteria: Synthesis, characterization and antibacterial activity.
    Hayee R; Iqtedar M; Albekairi NA; Alshammari A; Makhdoom MA; Islam M; Ahmed N; Rasool MF; Li C; Saeed H
    J Infect Public Health; 2024 May; 17(5):906-917. PubMed ID: 38569270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
    Witschi C; Doelker E
    J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient aggregation of chitosan-modified poly(d,l-lactic-co-glycolic) acid nanoparticles in the blood stream and improved lung targeting efficiency.
    Lee SY; Jung E; Park JH; Park JW; Shim CK; Kim DD; Yoon IS; Cho HJ
    J Colloid Interface Sci; 2016 Oct; 480():102-108. PubMed ID: 27421112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and in vitro/in vivo evaluation of PLGA microspheres containing norquetiapine for long-acting injection.
    Park CW; Lee HJ; Oh DW; Kang JH; Han CS; Kim DW
    Drug Des Devel Ther; 2018; 12():711-719. PubMed ID: 29670329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced cellular uptake and biodistribution of a synthetic cannabinoid loaded in surface-modified poly(lactic-co-glycolic acid) nanoparticles.
    Durán-Lobato M; Muñoz-Rubio I; Holgado MA; Alvarez-Fuentes J; Fernández-Arévalo M; Martín-Banderas L
    J Biomed Nanotechnol; 2014 Jun; 10(6):1068-79. PubMed ID: 24749401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Au-poly(lactic-co-glycolic) acid complex nanoparticles as ultrasound contrast agents: Preparation, characterization and in vitro study.
    Li XY; Xu L; Li HL; Du J; Liu XS; Li FH
    Mol Med Rep; 2018 Mar; 17(3):3763-3768. PubMed ID: 29286171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
    Niu X; Zou W; Liu C; Zhang N; Fu C
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and characterization of GRGDSPC-modified poly(lactide-co-glycolide acid) porous microspheres incorporated with protein-loaded chitosan microspheres for bone tissue engineering.
    Tao C; Huang J; Lu Y; Zou H; He X; Chen Y; Zhong Y
    Colloids Surf B Biointerfaces; 2014 Oct; 122():439-446. PubMed ID: 25074502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface modification of PLGA nanospheres with Gd-DTPA and Gd-DOTA for high-relaxivity MRI contrast agents.
    Ratzinger G; Agrawal P; Körner W; Lonkai J; Sanders HM; Terreno E; Wirth M; Strijkers GJ; Nicolay K; Gabor F
    Biomaterials; 2010 Nov; 31(33):8716-23. PubMed ID: 20797782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery.
    Wang N; Wu XS; Li JK
    Pharm Res; 1999 Sep; 16(9):1430-5. PubMed ID: 10496661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(lactic-co-glycolic) acid as a carrier for imaging contrast agents.
    Doiron AL; Homan KA; Emelianov S; Brannon-Peppas L
    Pharm Res; 2009 Mar; 26(3):674-82. PubMed ID: 19034628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.